Prof. Pierre Marquet (Head of INSERM U1248 IPPRITT) elected to be Chair of EACPT

On June 7th 2019, Prof. Pierre Marquet (Head of the INSERM U1248) has been elected to be President of EACPT (European Association for Clinical Pharmacology and Therapeutics), within the executive committee. He will be appointed for 6 years, (Chair – 2019-2021, Chairperson – [...]

First structural elucidation of the human ABCC4/MRP4 exporter in lipid bilayers

The ABCC4/MRP4 exporter has a clinical impact on membrane transport of a broad range of xenobiotics. It is expressed at key locations for drug disposition or effects such as in the liver, the kidney and blood cells. Several polymorphisms and mutations (e.g., p.Gly187Trp) leading to MRP4 [...]

Review: Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose

Due to a high inter-individual variability in its pharmacokinetics, tacrolimus dose individualization is mandatory. Even though the expert opinion has defined the area under the curve (AUC) as the best marker to use when performing dose adjustment of tacrolimus, most centres only use trough [...]

Roland Lawson récompensé pour la pédagogie en ligne

À l’occasion du 22e congrès annuel de la Société Française de Pharmacologie et de Thérapeutique(SFPT), Roland Lawson (post-doctorant chargé de cours de pharmacologie à la faculté de Pharmacie) a obtenu le prix du meilleur poster modéré de la session pharmacovigilance. Le travail présenté [...]

Previous Next

News

23 AOÛT2019
AU
01 JAN2019

PhD Position available in Computational Chemistry

PhD Position available at INSERM U1248 [...]

Univ. Limoges News

INSERM News

Organ transplantation repairs broken human being. It is among the most promising techniques to repair any single damaged part of a body in the near future. The INSERM U1248 IPPRITT unit is part of the hospital-university “Survival oPtimization in ORgan Transplantation” (FHU SUPORT) federation.

Owing to its translational research strategy, as led by clinicians, biologists, pharmacologists and physical-chemists, IPPRITT has developed both basic and clinical research programmes and tools to improve transplant patient care. The findings (mainly in pharmacology) are transferred to the clinics, aiming at the development of personalized medicine.

IPPRITT Events

04 JUIL2019

IPPRITT - Summer Event

Site des Chabannes
14 MAI2019

HDR Defense - Florent Di Meo

R26, CBRS
19 DÉC2018

Raclette du Labo

IPPRITT